Chola Securities: Midcap Stocks Set for Major Upside
By Business Desk
Chola Securities predicts Nifty Midcap 100 to hit 65,000 soon, highlighting Dixon Technologies, BHEL, and Biocon for growth amid India’s economic expansion.
🔥 Main Takeaway
Chola Securities is super bullish on the Nifty Midcap 100, predicting a rally to 65,000 soon, driven by strong market signals and key sector growth.
📌 What Happened?
Chola Securities issued a positive outlook for the Nifty Midcap 100 index on July 19, 2026, anticipating significant upward movement.
They project the index to climb to the 65,000 level within the short to medium term, specifically 1-4 weeks.
This optimistic forecast is backed by a robust Relative Strength Index (RSI), which indicates increased buying activity and a positive trendline breakout.
The brokerage identified 61,000 as a key support level, with 59,000 serving as the next important support if market conditions weaken.
Three specific midcap stocks—Dixon Technologies, BHEL, and Biocon—were highlighted by Chola Securities for their strong growth potential.
💰 Why It Matters
This signals significant momentum for Indian midcap companies, reflecting growing investor confidence in their underlying growth stories.
Dixon Technologies, an Electronics Manufacturing Services (EMS) powerhouse, has already seen an 18.27% rise this year and is set to benefit from India’s rapidly expanding electronics manufacturing sector.
BHEL, a leader in capital goods and power equipment, surged 44.55% year-to-date, poised for further gains from extensive infrastructure and power investments across the nation.
Biocon, operating in the pharma and biotech sector, shows a 12.93% increase this year, tapping into increasing healthcare demand and future product launches.
The positive RSI trend suggests a broader market appetite for risk and growth, making mid-sized companies attractive to investors.
👀 What to Watch Next
Keep a close eye on the Nifty Midcap 100’s performance as it targets the 65,000 level in the coming weeks.
Monitor the individual stock movements of Dixon Technologies, BHEL, and Biocon as sector-specific catalysts continue to unfold.
Watch for broader economic developments in India that could either accelerate or temper the projected midcap growth.